PLT-011

N/A

Report date: 2025/06/11 10:38:29

Base Information

Drug NamePLT-011

Drug Alias Nameanti-PDL1 antibody/IL10 fusion protein (Pilatus Biosciences)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed death-ligand 1 blockersInterleukin-10 inhibitors

TargetsInterleukin-10Programmed death-ligand 1

Therapy Area/IndicationsCarcinoma, HepatocellularNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPilatus Biosciences SA

China Registration ClassN/A

Develop Information

Active CompaniesPilatus Biosciences SA

Inactive CompaniesN/A

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A